Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2017OncotargetOpen Access

Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria

View Full Paper
Ask AI
Bookmark
Share

Key result

Kalirin and CHD7 levels in circulating extracellular vesicles were increased in albuminuric hypertensive patients and positively correlated with the endothelial activation marker E-selectin.

Population

Hypertensive patients with albuminuria and in vitro TNFα-treated adult human endothelial cells

Design

Cross-sectional

Authors

FCFernando de la CuestaHospital Universitario La PazMBMontserrat Baldán‐MartínHospital Universitario de La PrincesaRMRafael Moreno‐LunaServicio de Salud de Castilla La Mancha

Discussion

Loading...

Member takes

Implication

May support EV-based endothelial biomarkers in albuminuric hypertension; leaves open validation and prognostic utility in prospective studies.

Study Design

Type

Observational

Structured PICO

P
Population
Hypertensive patients with albuminuria (under Renin-Angiotensin-System suppression) and in vitro TNFα-treated adult human endothelial cells
O
Outcome
Protein levels of kalirin and CHD7 in circulating extracellular vesicles and their correlation with endothelial activation marker E-selectinsurrogate

Kalirin and CHD7 in circulating extracellular vesicles may serve as novel biomarkers for endothelial dysfunction to monitor vascular condition in hypertensive patients with albuminuria.

Cite This Study

Cuesta et al. (2017) conducted an observational in Hypertension with albuminuria. Kalirin and CHD7 in circulating extracellular vesicles was evaluated on Protein levels of kalirin and CHD7 and correlation with E-selectin. Kalirin and CHD7 levels in circulating extracellular vesicles were increased in albuminuric hypertensive patients and positively correlated with the endothelial activation marker E-selectin.

synapsesocial.com/papers/6a89a377186271ac9933494ehttps://doi.org/10.18632/oncotarget.14948

Topics

Hypertension management
View Full Paper
Ask AI
Bookmark
Share